Tumor Disease Samples

Central BioHub offers Tumor Disease Samples which encompass laboratory parameters like Lactate dehydrogenase, Cancer-Antigen 125, Protein S-100, Cancer-Antigen 19-9 or Prostate specific antigen. Furthermore, you can use the filter functions to refine your search. For normal control groups please switch to the category Healthy Donors. If you do not find the research samples you are looking for, please contact us.

Available filters
-
-
26,938 Products

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Female Age: 84
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - M1, stage IV, non-resectable (not specified)
Medication:
Actrapid
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
Gender:
Female
Age:
84 Years
BMI:
26.7 kg/m²
Weight:
65 kg
Height:
156 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - M1, stage IV, non-resectable (not specified)
Medication:
  • Actrapid
  • Carmen
  • Moxonidin
  • Protaphane
  • acetylsalicylic acid (ASA) (Dosages: 100not specified)
  • bisoprolol (Dosages: 2not specified)
  • hydrochlorothiazide (HCT) (Dosages: 25mg)
  • insulin
  • omeprazole (Dosages: 20mg)
  • simvastatine (Dosages: 20mg)
  • valsartan (Dosages: 160mg)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 154.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual: I100490049
Quant: 94.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.95 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 12.70 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 285.00 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 115.00 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 35.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 44.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 10.40 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 67.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289549
1 mL ($43.13)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.2

Donor:
Gender: Female Age: 72
Diagnosed disease:
C25.2 - Malignant neoplasm of tail of pancreas - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
Candesartan/candesartan
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
Gender:
Female
Age:
72 Years
BMI:
26.6 kg/m²
Weight:
68 kg
Height:
160 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of tail of pancreas [C25.2] - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
  • Candesartan/candesartan (Dosages: 16mg)
  • Digimerck
  • acetylsalicylic acid (ASA) (Dosages: 103not specified)
  • bisoprolol (Dosages: 5mg)
  • ciprofloxacin
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 161.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 26.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 10.70 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 33.70 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 105.00 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 79.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 163.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100490069
Quant: 20.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 11.60 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 29.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307943
0.9 mL ($38.81)
Available ($225.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Female Age: 59
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N0, M0, stage IIA, resectable (not specified)
Medication:
Addel
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Hemoglobin (Hb) Lipase Pancreatic Amylase
Donor:
Gender:
Female
Age:
59 Years
BMI:
24.8 kg/m²
Weight:
70 kg
Height:
168 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N0, M0, stage IIA, resectable (not specified)
Medication:
  • Addel
  • Aminoven
  • Cernevit
  • L-thyroxine
  • Meronem
  • Pantozol
  • bisoprolol
  • lercanidipine
  • metoclopramide
  • potassium
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: positive
Quant: 283.00 U/L
Source: this donation
35-104 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 10.20 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 216.10 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 183.00 U/L
Source: this donation
Jun 42 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: positive
Quant: 61.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: positive
Quant: 49.00 U/L
Source: this donation
Okt 35 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 10.50 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 41.00 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: negative
Quant: 32.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308237
0.4 mL ($17.25)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Female Age: 67
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - M1, stage IV, non-resectable (not specified)
Medication:
Metoprolol
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) ...
Donor:
Gender:
Female
Age:
67 Years
BMI:
24.2 kg/m²
Weight:
65 kg
Height:
164 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - M1, stage IV, non-resectable (not specified)
Medication:
  • Metoprolol
  • ciprofloxacin
  • hydrochlorothiazide (HCT)
  • lisinopril
  • pantoprazole
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 212.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 18.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 13.22 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 8932.00 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 113.00 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 203.00 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 147.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 119.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 74.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 9.00 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 20.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307963
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Female Age: 78
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas
Medication:
Androcur
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Donor:
Gender:
Female
Age:
78 Years
BMI:
22.8 kg/m²
Weight:
62 kg
Height:
165 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0]
Medication:
  • Androcur (Dosages: 10mg)
  • Gynokadin (Dosages: 7not specified)
  • Kalinor
  • Novaminsulfon
  • Pantozol (Dosages: 40not specified)
  • acetylsalicylic acid (ASA) (Dosages: 101not specified)
Therapy:
  • material removal
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: I100490109
Quant: 89.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 1.20 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 2.90 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: I100490109
Quant: 26.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 34.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100490109
Quant: 30.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 21.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289376
1.2 mL ($51.75)
Available ($225.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Amylase, ... - C24.0

Donor:
Gender: Female Age: 78
Diagnosed disease:
C24.0 - Malignant neoplasm of extrahepatic bile duct - T3, N1, M0, stage IIB, resectable (not specified)
Medication:
Fenistil
Parameter:
Alkaline Phosphatase (ALP) Amylase Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb)
Donor:
Gender:
Female
Age:
78 Years
BMI:
24.3 kg/m²
Weight:
67 kg
Height:
166 cm
Sample:
Matrix:
EDTA plasma
Condition:
icteric
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of extrahepatic bile duct [C24.0] - T3, N1, M0, stage IIB, resectable (not specified)
Medication:
  • Fenistil (Fenistil dry)
  • L-thyroxine (Dosages: 25not specified)
  • Ramipril (Dosages: 5not specified)
  • hydrochlorothiazide (HCT) (Dosages: 25not specified)
  • pantoprazole (Dosages: 40not specified)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 299.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 214.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual:
Quant: 0.80 not specified
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual:
Quant: 164.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 235.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 110.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100489498
Quant: 37.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: I100489498
Quant: 13.90 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308307
0.4 mL ($17.25)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Male Age: 80
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - stage III, non-resectable (not specified)
Medication:
Fluvastatin
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
Gender:
Male
Age:
80 Years
BMI:
27.7 kg/m²
Weight:
80 kg
Height:
170 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - stage III, non-resectable (not specified)
Medication:
  • Fluvastatin (Dosages: 80mg)
  • Metoprolol (Dosages: 47not specified)
  • Moxonidin
  • Telmisartan
  • acetylsalicylic acid (ASA) (Dosages: 300mg)
  • hydrochlorothiazide (HCT)
  • lercanidipine (Dosages: 10mg)
  • metamizole (Dosages: 1g)
  • pantoprazole (Dosages: 40mg)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 110.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual: I100490095
Quant: 56.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 1.19 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 23.70 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: I100490095
Quant: 42.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100490095
Quant: 41.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 14.70 g/dl
Source: this donation
12.5-17.2 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 44.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307918
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Cancer-An... - C25.0

Donor:
Gender: Male Age: 58
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
Candesartan/candesartan
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Donor:
Gender:
Male
Age:
58 Years
BMI:
22.3 kg/m²
Weight:
63 kg
Height:
168 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
  • Candesartan/candesartan (Dosages: 2mg)
  • Pulmicort
  • Verapamil (Dosages: 120mg)
Therapy:
  • hemithyreoidectomy
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: I100490071
Quant: 57.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.71 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 108.80 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 18.00 U/L
Source: this donation
< 61 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100490071
Quant: 36.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 47.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307939
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Male Age: 56
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N0, M1 (not specified)
Medication:
Lantus
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Glucose Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Donor:
Gender:
Male
Age:
56 Years
BMI:
23 kg/m²
Weight:
68 kg
Height:
172 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N0, M1 (not specified)
Medication:
  • Lantus
  • Lasix (Dosages: 401not specified)
  • Pantozol (Dosages: 40mg)
  • fentanyl
  • insulin
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 413.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual: I100490104
Quant: 13.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 2.18 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 19.20 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 126.00 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: I100490104
Quant: 23.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 49.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 7.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307912
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Glutamate... - D37.70

Donor:
Gender: Male Age: 74
Diagnosed disease:
D37.70 - T2, N0, M0, stage IB, resectable (not specified)
Medication:
Actrapid
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
Gender:
Male
Age:
74 Years
BMI:
22.5 kg/m²
Weight:
69 kg
Height:
175 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • D37.70
Medication:
  • Actrapid
  • Metoprolol (Dosages: 47not specified)
  • Moxonidin (Dosages: 0.6not specified)
  • Ramipril (Dosages: 5not specified)
  • acetylsalicylic acid (ASA) (Dosages: 100not specified)
  • insulin
  • simvastatine (Dosages: 20not specified)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: I100490116
Quant: 72.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.26 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 12.10 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 92.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 45.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100490116
Quant: 36.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 10.60 g/dl
Source: this donation
12.5-17.2 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 48.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307896
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Glucose, ... - C25.2

Donor:
Gender: Male Age: 64
Diagnosed disease:
C25.2 - Malignant neoplasm of tail of pancreas - T4, N0, M0, stage III, non-resectable (not specified)
Medication:
Lantus
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Glucose Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Donor:
Gender:
Male
Age:
64 Years
BMI:
21.6 kg/m²
Weight:
67 kg
Height:
176 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of tail of pancreas [C25.2] - T4, N0, M0, stage III, non-resectable (not specified)
Medication:
  • Lantus
  • Metoprolol (Dosages: 47not specified)
  • Nitrendipin (Dosages: 20mg)
  • acetylsalicylic acid (ASA) (Dosages: 100mg)
  • insulin
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: I100490083
Quant: 103.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.70 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 0.60 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 212.00 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: I100490083
Quant: 24.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 49.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 5.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289544
1 mL ($43.13)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Glucose, ... - C25.0

Donor:
Gender: Male Age: 75
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
Clexane
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Donor:
Gender:
Male
Age:
75 Years
BMI:
31.6 kg/m²
Weight:
82 kg
Height:
161 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
  • Clexane (active agent: Enoxaparin sodium)
  • L-thyroxine
  • Lantus
  • Metoprolol
  • Nitrendipin
  • Ramipril
  • Tromcardin
  • hydrochlorothiazide (HCT)
  • insulin
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: I100490013
Quant: 99.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.78 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 11.90 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 55.00 U/L
Source: this donation
< 61 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 156.00 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 61.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 27.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289564
1 mL ($43.13)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Glucose, ... - C25.0

Donor:
Gender: Female Age: 64
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
L-thyroxine
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Donor:
Gender:
Female
Age:
64 Years
BMI:
28.4 kg/m²
Weight:
70 kg
Height:
157 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
  • L-thyroxine
  • antidepressants
  • metformin
  • omeprazole
  • paroxetine
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: I100490027
Quant: 75.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.25 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 17.50 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 24.00 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 175.00 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: I100490027
Quant: 27.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 81.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 26.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289559
1 mL ($43.13)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Male Age: 54
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
L-thyroxine
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
Gender:
Male
Age:
54 Years
BMI:
31.7 kg/m²
Weight:
96 kg
Height:
174 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
  • L-thyroxine (Dosages: 100not specified)
  • Lactrase
  • Pantozol (Dosages: 40mg)
  • Quetiapin (Dosages: 25mg)
  • RamiLich (Dosages: 5mg)
  • antidepressants
  • fluoxetine (Dosages: 20mg, Fluoxetin Neumax)
  • sedative
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 170.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual: I100490015
Quant: 37.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 16.71 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 2.50 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 239.00 U/L
Source: this donation
< 61 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 172.00 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 45.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 13.80 g/dl
Source: this donation
12.5-17.2 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 79.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289563
1 mL ($43.13)
Available ($225.00)

Human EDTA plasma - Cancer-Antigen 19-9 (CA 19-9), Hemogl... - C25.2

Donor:
Gender: Male Age: 82
Diagnosed disease:
C25.2 - Malignant neoplasm of tail of pancreas - T3, N0, M1, stage IV, non-resectable (not specified)
Medication:
Sortis
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Hemoglobin (Hb) Pancreatic Amylase
Donor:
Gender:
Male
Age:
82 Years
BMI:
25.3 kg/m²
Weight:
73 kg
Height:
170 cm
Sample:
Matrix:
EDTA plasma
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of tail of pancreas [C25.2] - T3, N0, M1, stage IV, non-resectable (not specified)
Medication:
  • Sortis
  • amlodipine
Therapy:
  • transplant
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: negative
Quant: 75.00 U/L
Source: this donation
40-129 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.50 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 407.80 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 49.00 U/L
Source: this donation
Okt 71 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: negative
Quant: 24.00 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: negative
Quant: 31.00 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: I100489688
Quant: 14.70 g/dl
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: positive
Quant: 12.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308273
0.5 mL ($21.56)
Available ($225.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Male Age: 69
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
Fenistil
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
Gender:
Male
Age:
69 Years
BMI:
24 kg/m²
Weight:
76 kg
Height:
178 cm
Sample:
Matrix:
EDTA plasma
Condition:
icteric
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, N1, M0, stage IIB, resectable (not specified)
Medication:
  • Fenistil
  • Metohexal
  • Pantozol
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: positive
Quant: 314.00 U/L
Source: this donation
40-129 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 20.90 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 993.30 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 82.00 U/L
Source: this donation
Okt 71 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: positive
Quant: 114.00 mg/dl
Source: this donation
74 - 106 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: positive
Quant: 129.00 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: positive
Quant: 104.00 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 43.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 12.90 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 21.00 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: positive
Quant: 9.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308259
0.5 mL ($21.56)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Female Age: 65
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, M1, stage IV, non-resectable (not specified)
Medication:
Candesartan/candesartan
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
Gender:
Female
Age:
65 Years
BMI:
21.9 kg/m²
Weight:
71 kg
Height:
180 cm
Sample:
Matrix:
Urine
Condition:
icteric
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, M1, stage IV, non-resectable (not specified)
Medication:
  • Candesartan/candesartan
  • Pantozol
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 196.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 139.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 14.64 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 1486.00 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 86.00 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 89.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 55.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100490111
Quant: 33.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 11.40 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 289.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307901
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Cancer-An... - C25.2

Donor:
Gender: Female Age: 61
Diagnosed disease:
C25.2 - Malignant neoplasm of tail of pancreas - M1, stage IV, non-resectable (not specified)
Medication:
Gabapentin
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
Gender:
Female
Age:
61 Years
BMI:
22.5 kg/m²
Weight:
48 kg
Height:
146 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of tail of pancreas [C25.2] - M1, stage IV, non-resectable (not specified)
Medication:
  • Gabapentin
  • Movicol
  • Novamin
  • Ossofortin
  • Targin
  • pantoprazole
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: I100490019
Quant: 62.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.29 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 1815.00 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 68.00 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100490019
Quant: 37.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 13.20 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 24.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289561
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Capsule-reactive protein (CRP), Capsu... - C18.6

Donor:
Gender: Male Age: 66 Ethnic group: European/Caucasian
Diagnosed disease:
C18.6 - Malignant neoplasm of descending colon
Medication:
Hygroton
Parameter:
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA) Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Male
Age:
66 Years
Ethnic group:
European/Caucasian
BMI:
34 kg/m²
Weight:
104 kg
Height:
176 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of descending colon [C18.6]
Medication:
  • Hygroton (Dosages: 25mg/day, active agent: chlorthalidone)
  • Metex (Dosages: 125mg/week)
  • Prednisolon (Dosages: 2mg/day)
  • Simvabeta (Dosages: 10mg/day)
  • amlodipine (Dosages: 5mg/day)
  • bisoprolol (Dosages: 5mg/day)
  • hydroxychloroquine (Dosages: 400/day)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) / anti-citrullinated Protein Antibodies (ACPA)
Qual: negative
Quant: < 8.00 IU/mL
Source: this donation
< 17.00 IU/mL
Method: not specified
System: Cobas Roche
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 27.20 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 34.37 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 29.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH292431
1 mL ($43.13)
Available ($225.00)

Human Serum - Anti-Thyroglobulin (aTg / TAK), Thyro... - E03.9

Donor:
Gender: Female Age: 51 Ethnic group: European/Caucasian
Diagnosed disease:
C64 - left (not specified)
Medication:
Cimicifuga
Parameter:
Anti-Thyroglobulin (aTg / TAK) Thyrotropin (TSH) Thyroxine free (fT4) Triglycerides Triiodothyronine free (fT3)
Donor:
Gender:
Female
Age:
51 Years
Ethnic group:
European/Caucasian
BMI:
27 kg/m²
Weight:
82 kg
Height:
173 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • depression
  • hypothyroidism [E03.9]
  • kidney cell carcinoma [C64] - left (not specified)
Medication:
  • Cimicifuga (Dosages: 2/day)
  • L-Thyrox (Dosages: 50µg, manufacturer: Hexal)
  • Remergil (Dosages: 15mg)
  • escitalopram (Dosages: 20mg)
Therapy:
  • surgery
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroglobulin (aTg / TAK)
Qual: negative
Quant: 28.10 kU/L
Source: this donation
< 40.00 kU/L
Method: CLIA (Chemiluminescence Immuno Assay)
System: Immulite Siemens
Anti-Thyroglobulin (aTg / TAK)
Qual: negative
Quant: 50.85 IU/mL
Source: this donation
< 100.00 IU/mL
Method: EIA (Enzyme Immuno Assay)
System: not specified not specified
Anti-Thyroglobulin (aTg / TAK)
Qual:
Quant: 460.20 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyrotropin (TSH)
Qual:
Quant: 3.17 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Thyroxine free (fT4)
Qual:
Quant: 10.00 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Triglycerides
Qual: negative
Quant: 1.48 mmol/L
Source: this donation
< 2.25 mmol/L
Method: not specified
System: not specified Beckman Coulter
Triiodothyronine free (fT3)
Qual:
Quant: 2.70 not specified
Source: previous donation
not specified not specified
Method: not specified
System: not specified not specified
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH341789
1 mL ($43.13)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Cancer-An... - C25.0

Donor:
Gender: Female Age: 59
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas
Medication:
Kreon
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
Gender:
Female
Age:
59 Years
BMI:
21.4 kg/m²
Weight:
50 kg
Height:
153 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0]
Medication:
  • Kreon (Dosages: 65000not specified)
  • Pantozol (Dosages: 40mg)
  • tilidine (Dosages: 5mg)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: I100490047
Quant: 86.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.34 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 37.30 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 36.00 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 60.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 47.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100490047
Quant: 38.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 12.90 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 2773.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289550
1 mL ($43.13)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Female Age: 64
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T3, N1, M1, stage IV, non-resectable (not specified)
Medication:
Metoprolol
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
Gender:
Female
Age:
64 Years
BMI:
27.3 kg/m²
Weight:
70 kg
Height:
160 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T3, N1, M1, stage IV, non-resectable (not specified)
Medication:
  • Metoprolol
  • pantoprazole
  • simvastatine
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: I100490031
Quant: 113.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 1.88 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 676.10 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 292.00 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 208.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100490031
Quant: 39.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 10.60 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 32.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289557
1 mL ($43.13)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Glycosyla... - C25.1

Donor:
Gender: Female Age: 59
Diagnosed disease:
C25.1 - Malignant neoplasm of body of pancreas - stage III, non-resectable (not specified)
Medication:
Agomelatin
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glucose Glycosylated hemoglobin (HbA1, HbA1c) Lipase
Donor:
Gender:
Female
Age:
59 Years
BMI:
34.5 kg/m²
Weight:
94 kg
Height:
165 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of body of pancreas [C25.1] - stage III, non-resectable (not specified)
Medication:
  • Agomelatin
  • L-thyroxine
  • antidepressants
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: I100490000
Quant: 50.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.48 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 24.30 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: negative
Quant: 19.00 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glucose
Qual: negative
Quant: 98.00 mg/dl
Source: this donation
60 - 110 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual:
Quant: 45.00 mmol/mol
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 14.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289567
1 mL ($43.13)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C24.0

Donor:
Gender: Male Age: 63
Diagnosed disease:
C24.0 - Malignant neoplasm of extrahepatic bile duct - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
Candesartan/candesartan
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
Gender:
Male
Age:
63 Years
BMI:
32.7 kg/m²
Weight:
99 kg
Height:
174 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of extrahepatic bile duct [C24.0] - T3, N0, M0, stage IIA, resectable (not specified)
Medication:
  • Candesartan/candesartan (Dosages: 16mg)
  • allopurinol
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 194.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual: I100490033
Quant: 76.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 10.30 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: negative
Quant: 20.50 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 216.00 U/L
Source: this donation
< 61 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 80.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100490033
Quant: 37.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 12.80 g/dl
Source: this donation
12.5-17.2 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 51.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289556
1 mL ($43.13)
Available ($225.00)

Human Serum - E74.3

Donor:
Gender: Male Age: 49 Ethnic group: European/Caucasian
Diagnosed disease:
C7.3
Medication:
L-thyroxine
Parameter:
Anti-Thyroglobulin (aTg / TAK)
Donor:
Gender:
Male
Age:
49 Years
Ethnic group:
European/Caucasian
BMI:
35 kg/m²
Blood type:
Not specified
Rhesus factor:
not specified
Weight:
120 kg
Height:
186 cm
Sample:
Matrix:
Serum
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Other disorders of intestinal carbohydrate absorption [E74.3]
  • hypothyroidism
  • thyroid carcinoma [C7.3]
Medication:
  • L-thyroxine (Dosages: 225µg)
  • metformin (Dosages: 1000ms)
Therapy:
  • radioiodine therapy
  • thyroid surgery
Parameter Result Ref. / Cut-Off Measuring Information
Anti-Thyroglobulin (aTg / TAK)
Qual: negative
Quant: 0.23 kIU/L
Source: previous donation
< 115.00 kIU/L
Method: not specified
System: Cobas Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH344222
1 mL ($43.13)
Available ($225.00)

Human EDTA plasma - Alkaline Phosphatase (ALP), Bilirubin... - C25.0

Donor:
Gender: Male Age: 51
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T2, M1, stage IV, non-resectable (not specified)
Medication:
Euthyrox
Parameter:
Alkaline Phosphatase (ALP) Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase Pancreatic Amylase ...
Donor:
Gender:
Male
Age:
51 Years
BMI:
44.8 kg/m²
Weight:
142 kg
Height:
178 cm
Sample:
Matrix:
EDTA plasma
Condition:
icteric
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
0
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T2, M1, stage IV, non-resectable (not specified)
Medication:
  • Euthyrox
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual: positive
Quant: 681.00 U/L
Source: this donation
40-129 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 12.30 mg/dl
Source: this donation
< 1 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 1000.00 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 1028.00 U/L
Source: this donation
Okt 71 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual: positive
Quant: 97.00 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual: positive
Quant: 81.00 U/L
Source: this donation
Okt 50 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100489733
Quant: 32.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual:
Quant: 11.30 g/dl
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: positive
Quant: 65.00 U/L
Source: this donation
13 - 60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Pancreatic Amylase
Qual: negative
Quant: 22.00 U/L
Source: this donation
13 - 53 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH308248
0.5 mL ($21.56)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Female Age: 74
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - T3, M1, stage IV, non-resectable (not specified)
Medication:
Dekristol
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glutamic oxaloacetic transaminase (GOT / ASAT / AST) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase ...
Donor:
Gender:
Female
Age:
74 Years
BMI:
18 kg/m²
Weight:
46 kg
Height:
160 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - T3, M1, stage IV, non-resectable (not specified)
Medication:
  • Dekristol (Dosages: 0.25mg)
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 132.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual:
Quant: 110.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: positive
Quant: 1.51 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 974.20 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 384.00 U/L
Source: this donation
< 36 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 45.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamic oxaloacetic transaminase (GOT / ASAT / AST)
Qual:
Quant: 34.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100490107
Quant: 38.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: negative
Quant: 11.90 g/dl
Source: this donation
11.8 -15.8 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 59.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH307906
0.9 mL ($38.81)
Available ($225.00)

Human Urine - Alkaline Phosphatase (ALP), Amylase, ... - C25.0

Donor:
Gender: Male Age: 62
Diagnosed disease:
C25.0 - Malignant neoplasm of head of pancreas - M1, stage IV, non-resectable (not specified)
Medication:
Pantozol
Parameter:
Alkaline Phosphatase (ALP) Amylase Bilirubin Cancer-Antigen 19-9 (CA 19-9) Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT) Glutamate pyruvate transaminase (GPT / ALAT, ALT) Glycosylated hemoglobin (HbA1, HbA1c) Hemoglobin (Hb) Lipase
Donor:
Gender:
Male
Age:
62 Years
BMI:
20.3 kg/m²
Weight:
60 kg
Height:
172 cm
Sample:
Matrix:
Urine
Condition:
perfect
Stored at:
< -18 degrees Celsius
Freeze-Thaw-Cycle:
1
Diseases:
  • Malignant neoplasm of head of pancreas [C25.0] - M1, stage IV, non-resectable (not specified)
Medication:
  • Pantozol
  • Ramipril
  • bisoprolol
Parameter Result Ref. / Cut-Off Measuring Information
Alkaline Phosphatase (ALP)
Qual:
Quant: 284.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Amylase
Qual: I100490042
Quant: 40.00 U/L
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Bilirubin
Qual: negative
Quant: 0.65 mg/dl
Source: this donation
< 1.2 mg/dl
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Cancer-Antigen 19-9 (CA 19-9)
Qual: positive
Quant: 1803.00 U/mL
Source: this donation
< 27 U/mL
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Gamma-Glutamyltransferase (gamma-GT, GGT, GGPT)
Qual: positive
Quant: 524.00 U/L
Source: this donation
< 61 U/L
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glutamate pyruvate transaminase (GPT / ALAT, ALT)
Qual:
Quant: 142.00 U/L
Source: this donation
Remarks: abnormal
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Glycosylated hemoglobin (HbA1, HbA1c)
Qual: I100490042
Quant: 38.00 mmol/mol
Source: this donation
Remarks: normal range
not specified not specified
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Hemoglobin (Hb)
Qual: positive
Quant: 12.20 g/dl
Source: this donation
12.5-17.2 g/dl
Remarks: sex dependent
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Lipase
Qual: negative
Quant: 40.00 U/L
Source: this donation
13-60 U/L
Method: not specified
System: not specified not specified
Measured in: EDTA plasma
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH289552
1 mL ($43.13)
Available ($225.00)

Human Li-heparin plasma - Capsule-reactive protein (CRP), Capsu... - C82.9

Donor:
Gender: Female Age: 35 Ethnic group: European/Caucasian
Diagnosed disease:
C82.9 - Follicular lymphoma, unspecified
Medication:
Metex
Parameter:
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
35 Years
Ethnic group:
European/Caucasian
BMI:
19 kg/m²
Weight:
58 kg
Height:
174 cm
Sample:
Matrix:
Li-heparin plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • Follicular lymphoma, unspecified [C82.9]
Medication:
  • Metex (Dosages: 15mg/week)
  • folic acid (Dosages: 5mg/week)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 11.10 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 9.40 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 21.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295902
1 mL ($43.13)
Available ($225.00)

Human K3EDTA plasma - Capsule-reactive protein (CRP), Capsu... - C82.9

Donor:
Gender: Female Age: 35 Ethnic group: European/Caucasian
Diagnosed disease:
C82.9 - Follicular lymphoma, unspecified
Medication:
Metex
Parameter:
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG Capsule-reactive protein (CRP) Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS) Rheumatoid Factor (RF) IgM Total Rheumatoid Factor (tRF)
Donor:
Gender:
Female
Age:
35 Years
Ethnic group:
European/Caucasian
BMI:
19 kg/m²
Weight:
58 kg
Height:
174 cm
Sample:
Matrix:
K3EDTA plasma
Condition:
perfect
Freeze-Thaw-Cycle:
1
Diseases:
  • Follicular lymphoma, unspecified [C82.9]
Medication:
  • Metex (Dosages: 15mg/week)
  • folic acid (Dosages: 5mg/week)
Parameter Result Ref. / Cut-Off Measuring Information
Anti-cyclic citrullinated Peptide (CCP) IgG / anti-citrullinated Protein Antibodies (ACPA) IgG
Qual: negative
Quant: < 7.00 U/mL
Source: this donation
< 17.00 U/mL
Method: ECLIA (Electro Chemiluminescence Immuno Assay)
System: Cobas 8000 Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 11.10 mg/L
Source: this donation
< 5.00 mg/L
Method: not specified
System: Modular Roche
Capsule-reactive protein (CRP)
Qual: positive
Quant: 9.40 mg/L
Source: this donation
< 5.00 mg/L
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Erythrocyte sedimentation rate (ESR) / blood sedimentation speed (BSS)
Qual:
Quant: 21.00 mm/1h
Source: this donation
not specified not specified
Method: not specified
System: not specified not specified
Rheumatoid Factor (RF) IgM
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 15.00 IU/mL
Method: TIA (Turbidimetric Immuno Assay)
System: Cobas 8000 Roche
Total Rheumatoid Factor (tRF)
Qual: negative
Quant: < 10.00 IU/mL
Source: this donation
< 14.00 IU/mL
Method: not specified
System: Modular Roche
Disclaimer
  • All products are intended for research or manufacturing purposes only. In particular, the direct application in humans or animals for therapeutic or diagnostic purposes is not permitted.
  • Molecular genetic tests that establish the donor's identity are prohibited.
  • Biospecimens should be treated as potentially infectious. Each specimen is to be used by qualified professionals only, who will safely handle and dispose of the products they receive.
  • An import permit for biological substances may be required, in which case it must be present for purchase.
CBH295901
1 mL ($43.13)
Available ($225.00)
  • <
  • 1
  • ...
  • ...
  • ...
  • ...